A prospective study of magnetic resonance imaging and ultrasonography (MRI/US)-fusion targeted biopsy and concurrent systematic biopsy with the average of 18-cores to detect clinically significant prostate cancer

A prospective study of magnetic resonance imaging and ultrasonography (MRI/US)-fusion targeted biopsy and concurrent systematic biopsy with the average of 18-cores to detect clinically significant prostate cancer - A prospective study of magnetic resonance imaging and ultrasonography (MRI/US)-fusion targeted biopsy and concurrent systematic biopsy with the average of 18-cores to detect clinically significant prostate cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025911

Enrollment

150

Registered

2017-01-30

Start date

2014-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

We add MRI/US fusion targeted biopsy with concurrent systematic biopsy

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients having cancer suspicious lesions on MRI were recruited in this study

Exclusion criteria

Exclusion criteria: Patients who MRI/US fusion-targeted and concurrent systematic biopsies were not performed

Design outcomes

Primary

Measure	Time frame
detection rates of clinically significant prostate cancer	—

Countries

Japan

Contacts

Public ContactYuji Hakozaki

Tokyo Metropolitan Police Hospital Department of Urology

yhakozaki11012@gmail.com+81-03-5343-5611

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026